Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
"USP9Y pseudogene 9" (USP9YP9) refers to a pseudogene related to the gene for ubiquitin specific peptidase 9, Y-linked (USP9Y). As a pseudogene, USP9YP9 does not encode a functional protein and is not considered a therapeutic target, receptor, enzyme, or related molecule. The canonical protein-coding gene, USP9Y, is an active deubiquitinase involved in spermatogenesis[3][4][6], but pseudogenes such as USP9YP9 are generally non-functional and are not included in gene databases as protein-coding or disease-associated genes[2][5]. There is no evidence supporting USP9YP9 as a drug target, therapeutic entity, biomarker, or participant in biological or disease processes. The existence of multiple USP9Y pseudogenes is recognized, and USP9YP9 likely refers to a genomic sequence homologous to USP9Y but lacking coding potential and biological/research/clinical significance[2][5]. This entry is therefore incorrect as a therapeutic or functional molecular target; the correct entity is "ubiquitin specific peptidase 9 Y-linked" (USP9Y).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on USP9Y pseudogene 9 (USP9YP9).